Your browser doesn't support javascript.
loading
PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma.
Tao, Hongru; Jin, Chen; Zhou, Liyuan; Deng, Zhenzhong; Li, Xiao; Dang, Wenzhen; Fan, Shijie; Li, Bing; Ye, Fei; Lu, Junyan; Kong, Xiangqian; Liu, Chuanpeng; Luo, Cheng; Zhang, Yuanyuan.
Afiliação
  • Tao H; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Jin C; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zhou L; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
  • Deng Z; Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Li X; University of Chinese Academy of Sciences, Beijing, China.
  • Dang W; Department of Oncology, Xinhua Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.
  • Fan S; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
  • Li B; University of Chinese Academy of Sciences, Beijing, China.
  • Ye F; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
  • Lu J; University of Chinese Academy of Sciences, Beijing, China.
  • Kong X; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China.
  • Liu C; Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Luo C; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang Y; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Cancer Res ; 84(3): 419-433, 2024 02 01.
Article em En | MEDLINE | ID: mdl-37991725
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferons / Melanoma Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferons / Melanoma Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China